EDIXOMED

Edixomed Ltd is working on a nitric oxide dressing for diabetic patients with chronic leg ulcers to enable rapid healing. The system delivers nitric oxide directly to the target tissues, helping to increase blood flow and stimulate wound healing.

#SimilarOrganizations #People #More

EDIXOMED

Industry:
Biotechnology Health Care

Founded:
2009-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Status:
Active

Contact:
44 20 7493 4546


Similar Organizations

panoptes-pharma-logo

Panoptes Pharma

Developing innovative small molecule drugs to treat eye diseases with high unmet medical need.

Current Employees Featured

hugh-griffith_image

Hugh Griffith
Hugh Griffith Director @ Edixomed
Director
2009-01-01

More informations about "Edixomed"

Edixomed - 2025 Company Profile & Team - Tracxn

Edixomed is a seed company based in Edinburgh (United Kingdom), founded in 2009 by Chris Wood. It operates as a Manufacturer of nitric oxide dressings for chronic diabetic wound โ€ฆSee details»

EDIXOMED LIMITED - LinkedIn

EDIXOMED LIMITED | 20 followers on LinkedIn.See details»

EDIXOMED LIMITED Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for EDIXOMED LIMITED of EDINBURGH. Get the latest business insights from Dun & Bradstreet. EDIXOMED โ€ฆSee details»

Edixomed: Breakthrough Wound Care Technology

May 3, 2018 Edixomedโ€™s technology effectively โ€œsuperchargesโ€ the bodyโ€™s own natural healing processes. In fact, recently published clinical research in diabetic foot ulcers, including infected ulcers, showed that the EDX110 patch achieved โ€ฆSee details»

30 Technologyโ€™s Clinically Validated Antimicrobial Nitric Oxide ...

Apr 19, 2023 30 Technology, the world leader in clinical nitric oxide generation technology for health care, today announced that it has completed the sale of its antimicrobial nitric oxide โ€ฆSee details»

Edixomed - 2025 Funding Rounds & List of Investors - Tracxn

Jul 7, 2025 Explore Edixomed's funding history with round-wise details and complete investor list. Edixomed has raised a total funding of $2.2M over 3 rounds from 6 investors. Investors โ€ฆSee details»

Edixomed - Growth Outlook - Crunchbase

Edixomed Growth Score. 49 CB Rank. 388304 Heat Score. 57 Save Actions . Edixomed is working on a nitric oxide dressing for diabetic patients with chronic leg ulcers to enable rapid โ€ฆSee details»

Edixomed: Breakthrough Wound Care Technology โ€ฆ

May 1, 2018 Edixomed is a biopharmaceutical company commercialising next generation and clinically-proven technologies from its nitric oxide platform. Using its patented scientific approach, the company's ...See details»

Nitric Oxide Generating Gel Dressing in Patients With Diabetic โ€ฆ

Male or female patients aged over 18 years. Diagnosed with type 1 or type 2 diabetes. With a chronic (present for at least 6 weeks) full-thickness foot ulcer (on or below the malleoli) not โ€ฆSee details»

Convatec secures a highly innovative technology platform in the โ€ฆ

Apr 19, 2023 About Convatec. Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions โ€ฆSee details»

Edixomed - Funding, Financials, Valuation & Investors - Crunchbase

Edixomed is working on a nitric oxide dressing for diabetic patients with chronic leg ulcers to enable rapid healing. New. Resources. Advanced Search. ... How much funding has this โ€ฆSee details»

Edixomed's Nitric Oxide Generating Dressing Achieves Significant ...

Jun 10, 2015 Edixomed Limited is a clinical-stage biopharmaceutical company developing an innovative and active nitric oxide generating technology that has broad medical application in โ€ฆSee details»

EdixoMed Ltd.:Company Profile & Technical Research,Competitor โ€ฆ

EdixoMed Ltd. is a company that provides Nitric oxide, Adoption study, Chronic leg ulcers and more. EdixoMed Ltd. is headquartered in United Kingdom . EdixoMed Ltd. was founded in โ€ฆSee details»

EdixoMed Ltd - VentureRadar

EdixoMed is developing a novel nitric oxide-generating technology with a broad clinical application in a wide variety of diseases. The EdixoMed Dermatology Division has already generated โ€ฆSee details»

SBRI Healthcare - Edixomed

About us. About us; Support for Innovators; Independent Strategy Advisory Board; Policies; Competitions. Open Competitions; Closed Competitions; How to applySee details»

EDIXOMED LIMITED - Companies House

EDIXOMED LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business activity. โ€ฆSee details»

Edixomed - Contacts, Employees, Board Members, Advisors

Edixomed is working on a nitric oxide dressing for diabetic patients with chronic leg ulcers to enable rapid healing. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. โ€ฆSee details»

New Dressing for Foot Ulcers - DSM - Diabetes Self-Management

Jun 19, 2018 The next step for Edixomed is to secure government approval for the clinical use of EDX110. The company hopes that the technology can eventually be used not only for diabetic โ€ฆSee details»

Edixomed Limited · 1 Lochrin Square, 92-98 Fountainbridge, โ€ฆ

Edixomed Limited is an entity registered with the Companies House, Department for Business, Energy & Industrial Strategy, United Kingdom. The company number is #SC363191. The โ€ฆSee details»

Edixomed - Profiles & Contacts - Crunchbase

Edixomed is working on a nitric oxide dressing for diabetic patients with chronic leg ulcers to enable rapid healing. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. โ€ฆSee details»

linkstock.net © 2022. All rights reserved